Filing Details
- Accession Number:
- 0001140361-14-022253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-19 18:27:46
- Reporting Period:
- 2014-05-16
- Filing Date:
- 2014-05-19
- Accepted Time:
- 2014-05-19 18:27:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949 | Svp, Chief Commercial Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-05-16 | 1,004 | $56.91 | 20,980 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 plan executed on December 12, 2013.
- The price in column 4 is a weighted average price. The price actually received ranged from $56.15 to $57.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold t each price within the range.
Billionaire Hedge Funds
